Navigation Links
A 'LEAP' in controlling cardiac fibrillation
Date:7/14/2011

This release is available in German.

An international team of scientists from the Max Planck Institute for Dynamics and Self-Organization (Gttingen, Germany), Cornell University (Ithaca, New York) the Ecole Normale Suprieure de Lyon (France), the University Medicine Gttingen (Germany), the Rochester Institute of Technology (USA), and the Institut Non-Linaire de Nice (France) have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart. They have shown that their new technique called LEAP (Low-Energy Anti-fibrillation Pacing) reduces the energy required for defibrillation by more than 80% as compared to the current conventional method. Their discovery opens the path for the painless therapy of life threatening cardiac fibrillation. The scientists describe their results in the current issue of Nature.

In a healthy heart, electrical pulses that propagate across the heart muscle in an orderly fashion control the organ's movements: at regular intervals the heart's ventricles and atria contract and relax again. In the case of cardiac arrhythmia, however, this does not work reliably. Here, electrical pulses may propagate throughout the heart chaotically, disabling the regular heartbeat and thus preventing the body from being properly supplied with blood. The most common cardiac arrhythmia is atrial fibrillation, which affects more than 10 million people in Europe and US.

For patients suffering from chronic atrial fibrillation there is one reliable solution: a defibrillation. A strong electric pulse, which patients perceive as painful and which can damage the surrounding tissue forces the heart back into its regular beating. The international team of scientists led by Stefan Luther from the Max Planck Institute and Flavio Fenton from Cornell University has proposed a new method. Using a cardiac catheter the researchers create a sequence of five weak electrical signals in the heart. "Only a few seconds later, the heart beats regularly again", says Luther describing the team's newest results.

Even though LEAP and standard defibrillation seem to work similarly at first sight, they initiate completely different processes within the heart. "The classic defibrillator works by using a very strong electric field that excites all cells of the organ. In contrast, LEAP uses low-energy pulses to synchronize the tissue", says Fenton. For a short moment they can no longer transmit any electrical signals; the chaotic activity is terminated. "Afterwards, the heart resumes its normal, regular beating. The situation can be compared to turning a malfunctioning computer off and on again," says Robert Gilmour from Cornell University.

The new method terminates the turbulent electric activity within the heart step by step. "Our most important allies are natural heterogeneities within the heart such as blood vessels, fatty tissue or fibrotic tissue", says Eberhard Bodenschatz from the Max Planck Institute. In experiments and computer simulations the researchers were able to show that these heterogeneities can act as the origins for synchronizing waves. "Quite weak electrical pulses suffice to stimulate the cells in these regions", says Alain Pumir from Lyon. With every additional pulse more heterogeneities are activated thus gradually suppressing chaotic activity. "The heterogeneities act as small control sites that once activated can "reprogram" the entire organ", adds Valentin Krinsky from Nice.

In principle, the results also apply for defibrillation of ventricular fibrillation, a life-threatening arrhythmia, which is terminated only by external and implantable defibrillators. For a large number of patients wearing implantable cardioverter-defibrillators (ICD) the new technique may eliminate pain, improve the success rate of treatment, prolong battery life and therefore reduce the need for surgical device exchanges.

"The development of LEAP is a groundbreaking result and an outstanding example of successful interdisciplinary collaboration between physicists and physician-scientists, with immediate impact on the development of novel therapies for life-threatening cardiac arrhythmias", says Markus Zabel from the University Center Gttingen. The ideas leading to LEAP were first developed by asking elementary physical questions about the interaction between electric field and cardiac tissue; the results of earlier theoretical work in physics, in particular in the French National Center for Scientific Research (CNRS), may be finding their way to clinics. Indeed, "we are working to get this to the patient as fast as possible", adds Gerd Hasenfuss, the head of the Heart Center Gttingen.


'/>"/>

Contact: Dr. Birgit Krummheuer
birgit.krummheuer@ds.mpg.de
49-551-517-6668
Max-Planck-Gesellschaft
Source:Eurekalert  

Related medicine news :

1. Researchers make the leap to whole-cell simulations
2. Lupus Treatment May Soon Take Leap Forward
3. Scientists make leap forward in early detection for Alzheimers and cancer
4. Leap forward in efforts to develop treatments for Huntingtons disease
5. Founder of the LEAP Foundation to be Honored for Haiti Aid Efforts at The Aesthetic Meeting 2010
6. New Lucian Leape Institute Report Finds That U.S. Medical Schools Are Falling Short in Teaching Physicians How to Provide Safe Patient Care
7. A step toward controlling Huntingtons disease?
8. Controlling partners suffer more conflict with sexual desire
9. Controlling brain circuits with light
10. Melatonin might help in controlling weight gain and preventing heart diseases associated with obesity
11. Studies Highlight Challenge of Controlling Resistant Bacteria in Hospitals
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A 'LEAP' in controlling cardiac fibrillation
(Date:12/8/2016)... ... 2016 , ... After enjoying record-breaking attendance at its last ... 33rd Annual Issues & Research Conference, March 2-3, 2017, at the Westin ... is “Persistent Challenges and New Opportunities: Using Research to Accelerate the Dialogue." 2016 ...
(Date:12/8/2016)... ... ... CURE Media Group, the nation’s leading digital and print media enterprise focused on ... efforts to combat lung cancer, announced CURE Media Group President Michael J. Hennessy, Jr. ... honored to team up with Upstage Lung Cancer in order to make major strides ...
(Date:12/8/2016)... (PRWEB) , ... December 08, ... ... Presence Suite 10.2 version gives development continuity to its innovative Unified Instance ... channels management capacity. In addition, this new version optimizes the unattended auto-dialing ...
(Date:12/8/2016)... Peachtree City, Ga (PRWEB) , ... December 08, ... ... and moving as soon after surgery as possible. With this in mind, SIGVARIS ... vein thrombosis (DVT or blood clot) during bed rest and provide the benefits ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... offices headquartered in Jefferson County, is announcing the launch of a charity drive ... The number of homeless women and children in Birmingham has grown steadily since ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) has been recognized ... Top Workplaces National Standard. To learn more about ... ... Inc.) ... survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational ...
(Date:12/8/2016)... Research and Markets has announced the addition ... Adhesion Type, Application, Usability - Forecast to 2025" report to ... , , ... poised to grow at a CAGR of around 3.2% from 2015 ... witnessing include advancements in extracellular microelectrode arrays and intracellular microelectrodes, research ...
(Date:12/8/2016)... Dec. 8, 2016  Pennsylvania Physician General Dr. ... and Alcohol Programs Gary Tennis released ... known as benzodiazepines, developed with the help of ... medications that are frequently prescribed for anxiety or ... used with opioid pain medications, benzodiazepines pose a ...
Breaking Medicine Technology: